Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic nucleotide-gated cation channel alpha-2 (CNGA2) is a vital protein in the olfactory signal transduction pathway, primarily localized in the cilia of olfactory sensory neurons [1][2]. It functions as a non-selective cation channel that opens in response to increased intracellular levels of cAMP, which is produced when odorant molecules activate G protein-coupled odorant receptors [3]. The resulting influx of sodium and calcium ions depolarizes the neuron, triggering action potentials that transmit smell information to the brain [1][4]. Beyond its fundamental role in olfaction, CNGA2 is a key model for understanding how cyclic nucleotides regulate ion channel gating and sensory perception [2]. Mutations in the CNGA2 gene are directly linked to anosmia (the loss of the sense of smell), emphasizing its necessity for sensory function [5]. While pharmacological targeting of CNGA2 is currently focused on experimental tools like L-cis-diltiazem, it remains a significant target for research into sensory disorders and potential regenerative therapies for olfactory loss [4][6]. References: [1] UniProt Consortium. (2023). UniProtKB - Q16280 (CNGA2_HUMAN). [2] Pifferi, S., et al. (2006). "The cyclic nucleotide-gated channel of olfactory sensory neurons." Flavour and Fragrance Journal. [3] Kleene, S. J. (2008). "The electrochemical basis of odor transduction." Chemical Senses. [4] Bradley, J., et al. (2005). "The cyclic nucleotide-gated channels of the olfactory system." Chemical Senses. [5] Sailani, M. R., et al. (2017). "Isolated congenital anosmia and CNGA2 mutations." Scientific Reports. [6] Haynes, L. W. (1992). "Block of the cyclic GMP-activated channel of vertebrate rod and cone photoreceptors by l-cis-diltiazem." Visual Neuroscience.
Binding of cyclic nucleotides (cAMP or cGMP) to the intracellular C-terminal domain induces a conformational change that opens the ion-conducting pore, permitting the influx of sodium and calcium ions.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic nucleotide-gated cation channel alpha-2 (CNGA2).